S 2022 United States Senate · 117th Congress

Ending the Diagnostic Odyssey Act of 2021

Summary

Ending the Diagnostic Odyssey Act of 2021 This bill allows state Medicaid programs to cover whole genome sequencing services for certain individuals. Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to an intensive care unit or seen by a medical specialist for a suspected genetic or undiagnosed disease, or (2) are suspected by a medical specialist to have a neonatal- or pediatric-onset genetic disease. The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.

Issues: ✓ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Jun 2021

Committee Review

Floor Vote

President

Introduced Jun 10, 2021 Last action Jun 10, 2021

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jun 10, 2021

Committee

Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4046-4047)

upper

Jun 10, 2021

Introduced

Introduced in Senate

upper

1 primary · 3 co-sponsors